Related Experiment Video

Updated: Jun 25, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

[Family and polygenic hypercholesteremia: similarities and differencies according to long-term clinical observations]

B M Lipovetskiĭ

    Terapevticheskii Arkhiv
    |March 4, 2009
    PubMed

    Insights

    Family and polygenic hypercholesterolemia (FHCE and PHCE) patients show distinct clinical features. However, regular statin treatment significantly reduces mortality and extends lifespan by approximately 11 years for both FHCE and PHCE.

    Area of Science:

    • Cardiology
    • Genetics
    • Metabolic Diseases

    Background:

    • Hypercholesterolemia, including familial (FHCE) and polygenic (PHCE) forms, presents significant cardiovascular risks.
    • Understanding the differences and similarities between FHCE and PHCE is crucial for effective patient management.

    Purpose of the Study:

    • To detect and analyze similarities and differences between patients with FHCE and PHCE.
    • To evaluate the impact of hypercholesterolemia on clinical presentation and outcomes.

    Main Methods:

    • A comparative study involving 100 FHCE patients and 80 PHCE patients with elevated LDL-C levels (≥ 4.3 mmol/l).
    • Analysis of demographic data, clinical symptoms, and cardiovascular event rates.

    Main Results:

    • Patients differed in age, gender, hypercholesterolemia severity, and clinical manifestations.
    • PHCE patients experienced high rates of myocardial infarction (50%), angina (18%), and cerebrovascular events (29%).
    • FHCE patients showed varied presentations, including asymptomatic cases (19%), myocardial infarction (33%), angina (15%), cerebrovascular events (12%), and aortic issues (9%).
    • Overall mortality was similar (32% FHCE, 33% PHCE).
    • Long-term statin therapy halved lethality in both groups and extended lifespan by an average of 11 years.

    Conclusions:

    • Regular treatment for hypercholesterolemia, particularly with statins, is vital for reducing mortality.
    • Effective management of FHCE and PHCE can significantly prolong patients' lives.
    Abstract

    More Related Videos

    LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

    LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

    Published on: November 17, 2018

    Related Concept Videos

    Pharmacogenomics: Identification of New Drug Targets01:29

    Pharmacogenomics: Identification of New Drug Targets

    Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
    Cholesterol: Significance and Regulation01:29

    Cholesterol: Significance and Regulation

    Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
    Considering cholesterol and...
    Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

    Blood Studies for Cardiovascular System III: Serum Lipid Profile

    Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
    Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
    Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
    Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

    Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

    Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
    Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

    Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

    Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
    Principles of Pharmacogenetics: Types of Genetic Variants01:27

    Principles of Pharmacogenetics: Types of Genetic Variants

    The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...